Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.

ADC Therapeutics SA is a clinical-stage biotechnology company, which engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.

Priority Technology Holdings, Inc. engages in collection, storage, lending, and sending money through its commerce engine. The firm provides merchant services, payables, banking, and treasury solutions. It operates through the following segments: Small and Medium-sized Businesses (SMB) Payments, Business-to-Business (B2B) Payments, and Enterprise Payments. The SMB Payments segment includes provision of full-service acquiring and payment-enabled solutions for business-to-consumer transactions. The B2B Payments segment relates to accounts for payable automation solutions to corporations, software partners, and financial institutions. The Enterprise Payments segment refers to provision of embedded finance and banking as a service (BaaS) solution to customers to modernize legacy platforms and accelerate software partners' strategies to monetize payments. The company was founded by John V. Priore, Thomas Charles Priore, and Sean Kiewiet in August 2005 and is headquartered in Alpharetta, GA.

Global Indemnity Group LLC provides diversified insurance and reinsurance services. It operates through the Penn-America and Non-Core Operations segments. The Penn-America segment distributes specialty property and casualty insurance products in the excess and surplus lines marketplace. The Non-Core Operations segment includes manufactured and dwelling home business, farm, ranch and equine business, specialty personal lines products such as motorcycle, watercraft, and certain homeowners. The company was founded in 2003 and is headquartered in Wilmington, DE.

Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.

Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman and Jacqueline Zummo in March 2006 and is headquartered in New York, NY.

Inspired Entertainment, Inc. is a game technology company, which engages in the provision of gaming systems. It operates through the following segments: Gaming, Virtual Sports, Interactive, Leisure, and Corporate Functions. The Gaming segment supplies gaming terminals as well as gaming software and games for the terminals. The Virtual Sports segment designs, develops, markets, and distributes ultra-high-definition games that create an always-on sports wagering experience in betting shops, other locations, and online. The Interactive segment uses unique interactive-only content to create games that are hosted on remote gaming servers. The Leisure segment offers gaming terminals and amusement machines to the leisure and hospitality sectors. The Corporate Functions segment includes selling, general and administrative expenses, depreciation and amortization, capital expenditures, and right of use assets. The company was founded on May 30, 2014 and is headquartered in New York, NY.

Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.

Core Molding Technologies, Inc. is an engineered materials company specializing in molded thermoplastic and thermoset structural products, principally in building products, utilities, transportation and powersports industries across North America. The company offers compression molding of sheet molding compound, resin transfer molding, liquid molding of dicyclopentadiene, spray-up and hand-lay-up, direct long-fiber thermoplastics and structural foam and structural web injection molding. The company was founded in 1996 and is headquartered in Columbus, OH.